AVAdeno: Non-interventional Study of Avastin 1st Line Therapy in Adenocarcinoma Patients of the Lung
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms AVAdeno
- Sponsors Roche
- 25 Jul 2017 Status changed from active, no longer recruiting to completed.
- 11 Oct 2016 Results of second interim analysis (990), presented at the 41st European Society for Medical Oncology Congress.
- 01 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.